Table 2.
Secondary outcomes: changes from baseline to 3 months
| Control (n = 15) | HBCR (n = 15) | Difference between the control and HBCR groups in the changes from baseline to 3 months | ||||||
|---|---|---|---|---|---|---|---|---|
| Baseline | 3 months | Change | Baseline | 3 months | Change | (95%CI) | P value | |
| BNP (pg/mL) | 192 ± 219 | 188 ± 229 | −4.3 ± 44.0 | 237 ± 263 | 211 ± 239 | −25.1 ± 81.4 | −20.8 (−69.8 to 28.2) | 0.39 |
| KCCQ | 74.1 ± 23.1 | 78.0 ± 23.0 | 3.9 ± 10.8 | 70.2 ± 25.6 | 70.3 ± 27.7 | 0.04 ± 7.2 | −3.9 (−10.8 to 3.0) | 0.26 |
| SPPB | 10.4 ± 2.2 | 10.5 ± 2.0 | 0.1 ± 0.2 | 11.1 ± 1.2 | 11.4 ± 1.1 | 0.2 ± 0.1 | 0.2 (−0.2 to 0.7) | 0.41 |
| Kihon checklist | 6.5 ± 3.7 | 4.8 ± 3.1 | −1.7 ± 2.2 | 6.1 ± 4.1 | 5.4 ± 2.9 | −0.6 ± 2.6 | 1.1 (−0.7 to 2.9) | 0.23 |
Data are expressed as mean ± standard deviation. P values are derived by unpaired t‐test.
95%CI, 95% confidence interval; BNP, brain natriuretic peptide; HBCR, home‐base cardiac rehabilitation; KCCQ, Kansas City Cardiomyopathy Questionnaire; SPPB, Short Physical Performance Battery.